JP Morgan Chase
EOLS icon

JP Morgan Chase’s Evolus EOLS Stock Holding History

JP Morgan Chase’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Sell
31,476
-194,126
-86% -$941K ﹤0.01% 5718
2025
Q4 		$1.5M Sell
225,602
-220,709
-49% -$1.5M ﹤0.01% 4321
2025
Q3 		$2.74M Sell
446,311
-246,175
-36% -$1.92M ﹤0.01% 3838
2025
Q2 		$6.38M Sell
692,486
-35,405
-5% -$362K ﹤0.01% 2932
2025
Q1 		$8.76M Buy
727,891
+589,742
+427% +$7.71M ﹤0.01% 2657
2024
Q4 		$1.53M Sell
138,149
-31,777
-19% -$447K ﹤0.01% 4346
2024
Q3 		$2.75M Sell
169,926
-44,028
-21% -$615K ﹤0.01% 3724
2024
Q2 		$2.32M Sell
213,954
-33,702
-14% -$415K ﹤0.01% 3648
2024
Q1 		$3.47M Buy
247,656
+209,183
+544% +$2.72M ﹤0.01% 3409
2023
Q4 		$405K Sell
38,473
-92,427
-71% -$827K ﹤0.01% 4927
2023
Q3 		$1.2M Buy
130,900
+96,731
+283% +$867K ﹤0.01% 3937
2023
Q2 		$248K Buy
34,169
+4,371
+15% +$37.7K ﹤0.01% 4952
2023
Q1 		$252K Sell
29,798
-80,668
-73% -$729K ﹤0.01% 4921
2022
Q4 		$829K Buy
110,466
+87,083
+372% +$674K ﹤0.01% 4181
2022
Q3 		$188K Buy
23,383
+1,860
+9% +$19.7K ﹤0.01% 4985
2022
Q2 		$250K Sell
21,523
-789
-4% -$9.31K ﹤0.01% 4955
2022
Q1 		$251K Buy
22,312
+5,199
+30% +$44.3K ﹤0.01% 5072
2021
Q4 		$111K Buy
17,113
+4,899
+40% +$33.6K ﹤0.01% 5627
2021
Q3 		$94K Sell
12,214
-292
-2% -$3.02K ﹤0.01% 5597
2021
Q2 		$159K Sell
12,506
-7,526
-38% -$82.8K ﹤0.01% 5346
2021
Q1 		$261K Sell
20,032
-43,102
-68% -$397K ﹤0.01% 5037
2020
Q4 		$212K Buy
63,134
+54,981
+674% +$206K ﹤0.01% 4790
2020
Q3 		$31K Buy
8,153
+778
+11% +$2.84K ﹤0.01% 5068
2020
Q2 		$39K Buy
7,375
+1,424
+24% +$6.56K ﹤0.01% 4902
2020
Q1 		$24K Sell
5,951
-102
-2% -$864 ﹤0.01% 4904
2019
Q4 		$73K Buy
6,053
+1,100
+22% +$15.5K ﹤0.01% 5001
2019
Q3 		$77K Buy
4,953
+1,908
+63% +$31.3K ﹤0.01% 4990
2019
Q2 		$44K Buy
3,045
+774
+34% +$15.3K ﹤0.01% 5216
2019
Q1 		$51K Sell
2,271
-107
-4% -$2.31K ﹤0.01% 5123
2018
Q4 		$28K Buy
2,378
+169
+8% +$2.41K ﹤0.01% 5250
2018
Q3 		$41K Buy
2,209
+1,181
+115% +$25.6K ﹤0.01% 5263
2018
Q2 		$29K Buy
1,028
+11
+1% +$194 ﹤0.01% 5233
2018
Q1 		$9K Buy
+1,017
New +$11.6K ﹤0.01% 5178

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's EOLS Position: Q1 2026 in Review

JP Morgan Chase reduced its Evolus (EOLS) stake by 86% in Q1 2026, selling an estimated $941K and leaving 31,476 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #5718.

JP Morgan Chase first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $8.76M in Q1 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • JP Morgan Chase held 31,476 shares of Evolus worth $124K as of Q1 2026.
  • JP Morgan Chase sold 194,126 Evolus shares in Q1 2026, an estimated $941K.
  • Evolus made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5718 holding.
  • JP Morgan Chase first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
  • JP Morgan Chase's Evolus position peaked at $8.76M in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.